Alcon SG&A Expenses 2019-2024 | ALC
Alcon annual/quarterly sg&a expenses history and growth rate from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Alcon sg&a expenses for the quarter ending December 31, 2024 were $802M, a 1.01% increase year-over-year.
- Alcon sg&a expenses for the twelve months ending December 31, 2024 were $3.250B, a 1.28% increase year-over-year.
- Alcon annual sg&a expenses for 2024 were $3.25B, a 1.28% increase from 2023.
- Alcon annual sg&a expenses for 2023 were $3.209B, a 4.6% increase from 2022.
- Alcon annual sg&a expenses for 2022 were $3.068B, a 0.26% decline from 2021.
| Alcon Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $3,250 |
| 2023 | $3,209 |
| 2022 | $3,068 |
| 2021 | $3,076 |
| 2020 | $2,694 |
| 2019 | $2,847 |
| 2018 | $2,801 |
| Alcon Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $802 |
| 2024-09-30 | $809 |
| 2024-06-30 | $837 |
| 2024-03-31 | $802 |
| 2023-12-31 | $794 |
| 2023-09-30 | $798 |
| 2023-06-30 | $832 |
| 2023-03-31 | $785 |
| 2022-12-31 | $762 |
| 2022-09-30 | $762 |
| 2022-06-30 | $803 |
| 2022-03-31 | $741 |
| 2021-12-31 | $813 |
| 2021-09-30 | $779 |
| 2021-06-30 | $785 |
| 2021-03-31 | $699 |
| 2020-12-31 | $737 |
| 2020-09-30 | $685 |
| 2020-06-30 | $595 |
| 2020-03-31 | $677 |
| 2019-12-31 | $714 |
| 2019-09-30 | $717 |
| 2019-06-30 | $760 |
| 2019-03-31 | $656 |
| 2018-12-31 | |
| 2018-09-30 | $692 |
| 2018-06-30 | $722 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $47.559B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.546B | 80.83 |
| Thermo Fisher Scientific (TMO) | United States | $161.389B | 19.52 |
| Edwards Lifesciences (EW) | United States | $44.842B | 29.34 |
| IDEXX Laboratories (IDXX) | United States | $35.412B | 40.95 |
| DexCom (DXCM) | United States | $27.957B | 43.21 |
| IQVIA Holdings (IQV) | United States | $27.056B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.200B | 25.88 |
| STERIS (STE) | Ireland | $22.012B | 25.17 |
| Waters (WAT) | United States | $20.277B | 28.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.073B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.659B | 14.96 |
| Hologic (HOLX) | United States | $13.095B | 14.13 |
| Sysmex ADR (SSMXY) | Japan | $11.834B | 0.00 |
| Penumbra (PEN) | United States | $11.498B | 90.25 |
| Globus Medical (GMED) | United States | $9.948B | 23.03 |
| Masimo (MASI) | United States | $8.815B | 36.99 |
| Teleflex (TFX) | United States | $6.409B | 9.87 |
| Glaukos (GKOS) | United States | $5.356B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.429B | 23.20 |
| TransMedics (TMDX) | United States | $3.126B | 91.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Veracyte (VCYT) | United States | $2.446B | 44.20 |
| Nihon Kohden (NHNKY) | Japan | $2.137B | 11.68 |
| LivaNova (LIVN) | United Kingdom | $2.047B | 12.43 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.638B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.340B | 6.78 |
| Pulse Biosciences (PLSE) | United States | $1.197B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.116B | 0.00 |
| Artivion (AORT) | United States | $1.024B | 95.96 |
| OPKO Health (OPK) | United States | $0.940B | 0.00 |
| AxoGen (AXGN) | United States | $0.732B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 35.80 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 13.94 |
| RxSight (RXST) | United States | $0.619B | 0.00 |
| SiBone (SIBN) | United States | $0.607B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.551B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.443B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 18.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.326B | 6.92 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.196B | 0.00 |
| 908 Devices (MASS) | United States | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 11.12 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |